Jeffrey M. Rowe

Jeffrey M. Rowe has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Zomedica Corp., Diplomat Pharmacy, Inc. and Zomedica Pharmaceuticals Corp. Over a trading history stretching from 9 October 2014 to 17 March 2025, the count stands at 19 filings.

On the open market, the record shows 12 purchases worth €177k and 5 sales worth €25.8M. On balance, insiders were net sellers of €25.6M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 option exercises. So far in 2025, the count stands at 12 purchases and no sales.

In size, the median ticket on the buying side is €5,331. On 6 out of 6 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 6 purchases show a median change of -44.2%, with the price up in 0% of them. They describe history only and say nothing certain about the share price ahead.

On 27 March 2025 came the latest disclosure, an open-market purchase for €46k in Zomedica Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.